Back

Intensive, early and sustained lowering of atherogenic lipoproteins after myocardial infarction and long-term prognosis: a nationwide cohort study of myocardial infarction patients

1 September 2024 (14:10 - 14:22)
Organised by: Logo
Congress Presentation Part of: Registries, observational, and other studies on lipids Lipids ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Ms Jessica Schubert

Uppsala University Hospital, Uppsala (Sweden)

5 More presentations in this session

Presentation thumbnail
LDL-Cholesterol levels and lipid lowering therapy in secondary prevention patients: preliminary data from BRING-UP Prevention Study
Doctor A. Maggioni (Florence, IT)
Slides Video
Presentation thumbnail
Suboptimal Lipid Measurement and Statin Use after Percutaneous Coronary Intervention is associated with Increased Mortality: Results of a Real World Registry of 76,264 Patients in NW London
Doctor M. Akhtar (London, GB)
Slides Video
Presentation thumbnail
Association of early versus late use of combination lipid-lowering therapy with major cardiovascular outcomes after myocardial infarction: data from the SWEDEHEART registry
Associate Professor M. Leosdottir (Malmo, SE)
Slides Video
Presentation thumbnail
A global perspective of Lp(a) levels in patients with coronary heart disease - Implications for risk factor control & future trials from the INTERASPIRE Study
Professor K. Ray (London, GB)
Slides Video
Presentation thumbnail
Optimising oral lipid-lowering therapy regimens in high and very high-risk statin intolerant patients with dyslipidaemia: A French real-world simulation
Professor F. Schiele (Besancon, FR)
Slides Video

Access the full session

Session thumbnail
Registries, observational, and other studies on lipids
Video

The Event

Event poster

ESC Congress 2024

1 September 2024 14:10 CET
You may be interested in
thumbnail
Congress Session
Registries, observational, and other studies on lipids
thumbnail
Congress Presentation
Association of early versus late use of combination lipid-lowering therapy with major cardiovascular outcomes after myocardial infarction: data from the SWEDEHEART registry
thumbnail
Congress Session
Late-Breaking Clinical Science: lipids and cardiovascular risk

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources